Clarus Therapeutics Holdings, Inc.
CRXTDelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817944
Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Clarus Therapeutics Holdings, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 13 | 25 | +12 |
| Shares | 2.50M | 4.78M | +2.28M (+91.0%) |
| Value | $3.73M | $1.82M | −$1.91M (−51.2%) |
New holders (13)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 323,800 | $124.0K | 0.00% |
| Sabby Management, LLC | 200,000 | $76.0K | 0.14% |
| Cetera Advisor Networks LLC | 63,000 | $24.0K | 0.00% |
| Powell Investment Advisors, LLC | 60,000 | $23.0K | 0.01% |
| Warberg Asset Management LLC | 55,000 | $21.0K | 0.01% |
| Ayrton Capital LLC | 32,525 | $12.0K | 0.02% |
| Squarepoint Ops LLC | 29,085 | $11.0K | 0.00% |
| State Street Corp | 25,536 | $10.0K | 0.00% |
| StoneX Group Inc. | 11,685 | $4.46K | 0.00% |
| Two Sigma Investments, LP | 10,001 | $4.00K | 0.00% |
| Advisor Group Holdings, Inc. | 10,000 | $4.00K | 0.00% |
| Wealthcare Advisory Partners LLC | 11,578 | $4.00K | 0.00% |
| Morgan Stanley | 6,957 | $3.00K | 0.00% |
Sold out (1)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Royal Bank of Canada | 500 | $1.00K |